Borregaard ASA(0QB7)
NOK --+0.00%
Reward60Moderate
Risk39Moderate
📊50%Data
2.9% dividend yield
0QB7
+0.0 · +0.00%
NOK · LSE
Borregaard ASA |
Quality Compounder
Market Cap:20.70Bn
ℹ️
Reward Rating
60
Moderate
Top 50% (model universe)
50% data coverage
ℹ️
Risk Rating
39
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0QB7 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Borregaard ASA?

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.

0QB7 · Verdict

Solid reward · moderate risk

0QB7 stands out on balance sheet and profitability, but watch the cash flow signal.

Based on 75% data coverage

0QB7 · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet80/100

    Current ratio 1.46

  • Profitability77/100

    11% return on equity

  • Volatility65/100

    Above average

Watchouts 1

  • Cash flow30/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Borregaard ASA?

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company is listed on the LSE in UK, with a market capitalisation of 20.70B.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (60)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap20.70B
P/E RatioN/A
Dividend Yield2.86%
52 Week High205.7494
52 Week Low142.6
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees1,193
IndustryN/A
ExchangeLSE
Beta0.674
CurrencyNOK